Fundz

Navrogen, Inc. reported raising $6.96 Million in an initial SEC Form D filing, from an offering of $7.96 Million

PRIVATEAug 12, 2021$7M of $8M raised

Amount Raised

$6.96 Million

$6.96 Million sold, per SEC Form D (first sale Aug 12, 2021)

Round Type

Venture

CheyneyBiotechnology

Quick answer

Navrogen, Inc. raised $6.96 Million in a funding round, dated August 12, 2021. Navrogen, Inc. is based in Cheyney, Pennsylvania, United States.

How much did Navrogen, Inc. raise?
Navrogen, Inc. raised $6.96 Million in a funding round on August 12, 2021.
What does Navrogen, Inc. do?
Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer.
Where is Navrogen, Inc. based and how big is it?
Navrogen, Inc. is based in Cheyney, Pennsylvania, United States.
Who are the decision-makers at Navrogen, Inc?
Fundz holds 1 contact at Navrogen, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Navrogen, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • VITROLABS INC raised $22M on September 24, 2021.
  • Garuda Therapeutics raised $48M on September 24, 2021.
  • NANO-C raised $8.5M on September 24, 2021.
  • Aurora Bio, Inc. raised $117M on September 24, 2021.
  • GenEdit raised an undisclosed amount (Series A) on September 23, 2021.
  • PhenoBiome raised an undisclosed amount (Funding Round) on September 23, 2021.

Who to call at Navrogen, Inc., and when

A new round usually means Navrogen, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Navrogen, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Navrogen, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Navrogen, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Navrogen, Inc.

Location

1837 UNIVERSITY CIR.

Cheyney, Pennsylvania, United States

About

Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer. Navrogen is currently working on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Navrogen, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLuigi G., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Navrogen, Inc.'s next move

See what Strategic adds

Navrogen, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.